CD8A and neoplasm: As the major executor of tumor immunology, CD8+ T cells are thought to differentiate into cytotoxic T cells (CTLs) and specifically recognize endogenous antigenic peptides presented by the major histocompatibility complex I, thereby eliminating tumor cells (Uzhachenko and Shanker, 2019).